Viking therapeutics (Nasdaq:Vsktx), Altimmum (Nasdaq:Bottom) and structural therapeutics (Nasdaq:GPCR) The following are one of the drug companies that develop weight loss treatment Disappoints Earlier Monday Novo Nordisk (Very cite) Next gene obesity medicine Cagrisma.